Pharmaceutical - AstraZeneca, Legal


Current filters:


Popular Filters

Report: Health care companies lead the way in corporate compliance


Health care companies are leading the way in terms of public trust and transparency, according to The…

AstraZenecaGlaxoSmithKlineLegalManagementPharmaceuticalReckitt BenckiserUK

Hanmi launches esomeprazole product in USA despite AstraZeneca litigation

Hanmi launches esomeprazole product in USA despite AstraZeneca litigation


South Korea-based Hanmi Pharmaceutical has announced that Esomezol (esomeprazole strontium) for the treatment…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumEsomeprazole SodiumGastro-intestinalsGenericsHanmi PharmaceuticalLegalNexiumPharmaceuticalUSA

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed


Secrets of how Bristol-Myers Squibb and AstraZeneca arranged a behind-the-scenes deal to buy Amylin were…

AmylinAstraZenecaBristol-Myers SquibbDiabetesInterviewsLegalMergers & AcquisitionsPharmaceuticalUKUSA

AstraZeneca “cooperating” with US DoJ inquiry into Brilinta trial

AstraZeneca “cooperating” with US DoJ inquiry into Brilinta trial


AstraZeneca said it is cooperating with the US Department of Justice after an investigation has been…


US Appeals Court lifts temporary injunction on Hanmi Nexium generic NDA


AstraZeneca said that the US Court of Appeals for the Federal Circuit (CAFC) lifted a temporary injunction…

AstraZenecaEsomeprazole MagnesiumGastro-intestinalsHanmi PharmaceuticalLegalNexiumNorth AmericaPharmaceuticalRegulation

US Appeals Court puts temporary stop on sales of generics of AstraZeneca's Pulmicort Respules


Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced last Friday (May 24) that the US Court of Appeals…

ActavisAstraZenecaGenericsLegalMarkets & MarketingNorth AmericaPharmaceuticalPulmicort RespulesRespiratory and Pulmonary

Japan Supreme Court absolves AstraZeneca over deaths associated with Iressa


The Japanese Supreme Court has upheld high court rulings that the Japanese unit of Anglo-Swedish drug…


US Court of Appeals confirms validity of AstraZeneca' Seroquel XR patent


AstraZeneca announced that, on 14 February 2013, the United States Court of Appeals for the Federal Circuit…

AstraZenecaGenericsLegalNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XR

EU Court of Justice dismisses AstraZeneca appeal on patent settlement


The European Union's highest court, the Court of Justice, yesterday dismissed the appeal of Anglo-Swedish…


Japan High Court rules in favor of AstraZeneca over Iressa deaths


Anglo-Swedish drug major AstraZeneca's (LSE: AZN) Japanese subsidiary has received a decision from the…


US court turns down AstraZeneca FDA injunction; Teva debuts generic Seroquel in UK


In another setback for Anglo-Swedish drug major AstraZeneca in its fight to delay generic competition…

AstraZenecaEuropeGenericsLegalNeurologicalNorth AmericaPatentsPharmaceuticalRegulationSeroquelSeroquel XR

AstraZeneca Seroquel XR patent ruled invalid in UK; eyeing Forest buy?


In another setback regarding intellectual property on its blockbuster antipsychotic drug, AstraZeneca…

AstraZenecaEuropeForest LaboratoriesLegalNeurologicalPatentsPharmaceuticalSeroquel XR

AstraZeneca in deal with Galapagos; view on Seroquel law suit


BioFocus and Argenta, service companies of Netherlands-based Galapagos (Euronext: GLPG), yesterday announced…

Argenta DiscoveryAstraZenecaBioFocusGalapagosLegalNeurologicalPharmaceuticalResearchRespiratory and PulmonarySeroquelSeroquel XR

AstraZeneca sues US FDA over Seroquel decision


Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced this morning that it has filed a law suit against…

AstraZenecaLegalNeurologicalNorth AmericaPharmaceuticalRegulationSeroquelSeroquel XR

EU Commission finds no evidence against AstraZeneca and Nycomed


The European Commission said yesterday that it has ceased its antitrust investigation into the pharmaceutical…

AstraZenecaEuropeLegalNycomedPatentsPharmaceuticalRegulationTakeda Pharmaceuticals

Company Spotlight



Back to top